Literature DB >> 12898662

The value of the change in health in Sweden 1980/81 to 1996/97.

Kristina Burström1, Magnus Johannesson, Finn Diderichsen.   

Abstract

The study aimed to estimate the value of the change in health in Sweden 1980/81 to 1996/97. Quality-adjusted life years (QALYs) for men and women at specific ages were estimated for 1980/81, 1988/89 and 1996/97, by combining survival rates and health state scores. Data from the Swedish Survey of Living Conditions (n = 39,966) were used to estimate age-specific health state scores. Responses to selected survey questions were mapped into the EQ-5D measure, using the UK EQ-5D index tariff to derive health state scores. The monetary value of a QALY was assumed to be 100,000 dollars. Life expectancy for infants increased by 3.68 years for males and 2.70 years for females between 1980/81 and 1996/97. Average health status decreased in younger age groups whereas it increased in older age groups. Expected QALYs for infants increased by 2.64 for males and 0.54 for females. With 3% discounting the gain was 0.11 QALYs (11,000 dollars) among males and a loss by 0.58 QALYs (58,000 dollars) among females. The corresponding gain in discounted QALYs for a 75-year-old was 1.15 (115,000 dollars) and 0.80 (80,000 dollars), respectively. It is concluded that older persons have experienced considerable health gains whereas the health gains have been small or non-existent for younger women. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12898662     DOI: 10.1002/hec.754

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  9 in total

Review 1.  Health related quality of life outcome instruments.

Authors:  Gunnar Németh
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

2.  Decision making with regard to antiviral intervention during an influenza pandemic.

Authors:  Eunha Shim; Gretchen B Chapman; Alison P Galvani
Journal:  Med Decis Making       Date:  2010 Jul-Aug       Impact factor: 2.583

3.  Deteriorating health status in Stockholm 1998-2002: results from repeated population surveys using the EQ-5D.

Authors:  Kristina Burström; Magnus Johannesson; Clas Rehnberg
Journal:  Qual Life Res       Date:  2007-09-09       Impact factor: 4.147

4.  Optimal H1N1 vaccination strategies based on self-interest versus group interest.

Authors:  Eunha Shim; Lauren Ancel Meyers; Alison P Galvani
Journal:  BMC Public Health       Date:  2011-02-25       Impact factor: 3.295

5.  The evolution of health status and chronic conditions in Catalonia, 1994-2006: the paradox of health revisited using the Blinder - Oaxaca decomposition.

Authors:  Anna García-Altés; Jaime Pinilla; Vicente Ortún
Journal:  BMC Health Serv Res       Date:  2011-05-23       Impact factor: 2.655

6.  Person-Centered Interactive Self-Management Support in Primary Health Care for People with Type 2 Diabetes: Protocol for a Randomized Controlled Trial.

Authors:  Ulrika Öberg; Ulf Isaksson; Lena Jutterström; Carljohan Orre; Åsa Hörnsten
Journal:  JMIR Res Protoc       Date:  2019-04-08

7.  Routine versus selective intraoperative cholangiography during cholecystectomy: systematic review, meta-analysis and health economic model analysis of iatrogenic bile duct injury.

Authors:  J M L Rystedt; J Wiss; J Adolfsson; L Enochsson; B Hallerbäck; P Johansson; C Jönsson; P Leander; J Österberg; A Montgomery
Journal:  BJS Open       Date:  2021-03-05

8.  Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general population.

Authors:  Fitsum Sebsibe Teni; Ulf-G Gerdtham; Reiner Leidl; Martin Henriksson; Mimmi Åström; Sun Sun; Kristina Burström
Journal:  Qual Life Res       Date:  2021-10-10       Impact factor: 4.147

9.  Swedish experience-based value sets for EQ-5D health states.

Authors:  Kristina Burström; Sun Sun; Ulf-G Gerdtham; Martin Henriksson; Magnus Johannesson; Lars-Åke Levin; Niklas Zethraeus
Journal:  Qual Life Res       Date:  2013-08-22       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.